Novartis has canceled the large investments planned for India, after the verdict of the Indian Court in Chennai which basically said: the local patent law is compatible with the rules of the World Trade Organization. Only that this law does not provide protection to medicines that bring marginal advantages compared to already approved active molecules. NCF of 04/12/2007 NOVEMBER 2007 p. 16
